George J. Arnaoutakis

George J. Arnaoutakis

Auto-generated profile, based on publicly available information

George J. Arnaoutakis

Division of Cardiac Surgery, Department of Surgery, The Johns Hopkins Hospital, 1800 North Orleans Street/Blalock 655, Baltimore, MD, 21287, USA,

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2021 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
JBJames A. Brown
James A. Brown
GAGeorge J. Arnaoutakis
George J. Arnaoutakis
WSWilson Y. Szeto
Wilson Y. Szeto
DSDerek Serna‐Gallegos
Derek Serna‐Gallegos
ISIbrahim Sultan
Ibrahim Sultan

1 May 2019 in Annals of Cardiothoracic Surgery
Verified
Journal Article
Closed access
PDF file
GAGeorge J. Arnaoutakis
George J. Arnaoutakis
ISIbrahim Sultan
Ibrahim Sultan
MSMary Siki
Mary Siki
JBJoseph E. Bavaria
Joseph E. Bavaria
Background: Many patients with bicuspid aortic valve (BAV) develop aortic regurgitation but are not considered for valve repair. This is partly due to limited long term data regarding repair durability. The purpose of the review is to summarize the long-term (1 year) outcomes of BAV repair. Methods: A systematic review was performed to evaluate durability and survival following BAV repair. OVID SP versions of MEDLINE and Embase were searched using ‘aortic valve’, ‘bicuspid’, ‘repair’, ‘David’ ‘Yacoub’, ‘reimplantation’ and ‘remodeling’. Results: Initial search produced 770 abstracts, reduced to 92 full papers for review after excluding duplications and abstract review for relevance. Twenty-six studies met full inclusion criteria. BAV repair revealed low operative mortality, with excellent 5-year survival, and low freedom from reoperation. Differences in surgical technique between reimplantation and remodeling do not appear to confer protection against reintervention. Systematic assessment of cusp height and annular stabilization in some form do appear to favor improved long term durability. Leaflet calcification is associated with higher rates of reintervention. Conclusions: BAV repair is associated with acceptable long term survival. Ongoing standardized outcome assessments will further refine surgical techniques associated with excellent repair durability.

15 July 2020 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
JBJames A. Brown
James A. Brown
GAGeorge J. Arnaoutakis
George J. Arnaoutakis
AKArman Kilic
Arman Kilic
TGThomas G. Gleason
Thomas G. Gleason
EAEdgar Aranda-Michel
Edgar Aranda-Michel
ISIbrahim Sultan
Ibrahim Sultan

1 December 2010 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Open access
GAGeorge J. Arnaoutakis
George J. Arnaoutakis
JAJeremiah G. Allen
Jeremiah G. Allen
CMChristian A. Merlo
Christian A. Merlo
WBWilliam A. Baumgartner
William A. Baumgartner
JCJohn V. Conte
John V. Conte
ASAshish S. Shah
Ashish S. Shah
The ideal solution for recovery of donor lungs remains unknown. Low potassium dextran (LPD) solution is most common, but University of Wisconsin (UW) solution is also used. The United Network for Organ Sharing (UNOS) database allows assessment of preservation solutions in a large cohort of lung transplant (LTx) patients. We retrospectively reviewed the UNOS data set for adult primary LTx patients (2005-2008) whose donor lungs were recovered with UW or LPD solution. Patients were stratified by UW vs LPD, and secondarily grouped by quartiles of the lung allocation score (LAS) to examine high-risk recipients. Kaplan-Meier (KM) short-term mortality (30 days, 90 days, 1 year) and rejection in the first year were examined for intervals with adequate follow-up. Cox proportional hazard regression using 11 variables examined all cause 1-year mortality. Of 4,455 patients, 4,161 (93.4%) received LPD lungs and 294 (6.6%) received UW lungs, and 1,105 patients (24.8%) died during the study. There was no mortality difference based on flush solution with all patients examined together. However, patients in the upper 2 LAS quartiles (Q3: 37.8-45.4, Q4: > 45.4) receiving LPD lungs had greater 1-year survival of 81.5% vs 73.5% (p = 0.02). On multivariable analysis, flush with UW solution resulted in an increased risk of 1-year mortality (hazard ratio, 1.77. 95% confidence interval, 1.21-2.58; p = 0.003) vs LPD. Preservation solution did not affect rejection rates in the year after LTx. KM modeling demonstrated the effect of flush solution on survival (p = 0.02). This study is the largest modern cohort to evaluate the effect of donor lung flush solutions on survival in adult LTx. UW solution increases the risk of 1-year mortality in high-risk LTx recipients.

16 September 2020 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
GAGeorge Arnaoutakis
George Arnaoutakis
VBValentino Bianco
Valentino Bianco
AEAnthony L. Estrera
Anthony L. Estrera
DBDerek R. Brinster
Derek R. Brinster
MEMarek P. Ehrlich
Marek P. Ehrlich
ISIbrahim Sultan
Ibrahim Sultan

20 December 2013 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
GAGeorge J. Arnaoutakis
George J. Arnaoutakis
GBGregory J. Bittle
Gregory J. Bittle
JAJeremiah G. Allen
Jeremiah G. Allen
EWEric S. Weiss
Eric S. Weiss
JAJennifer Alejo
Jennifer Alejo
JCJohn V. Conte
John V. Conte